95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-199.50%
Negative revenue growth while FSM stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-199.50%
Negative gross profit growth while FSM is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-251.32%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-251.32%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-511.39%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-511.27%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-511.27%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1856.19%
OCF growth above 1.5x FSM's 43.85%. David Dodd would confirm a clear edge in underlying cash generation.
1856.19%
FCF growth above 1.5x FSM's 43.85%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-278.69%
Negative 10Y revenue/share CAGR while FSM stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-278.69%
Negative 5Y CAGR while FSM stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-36363820.17%
Negative 3Y CAGR while FSM stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.92%
Negative 3Y OCF/share CAGR while FSM stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-31219.63%
Negative 3Y CAGR while FSM is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while FSM shows 424.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while FSM stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-41.90%
Negative asset growth while FSM invests at 81.67%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-33.48%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-100.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-190.08%
We cut SG&A while FSM invests at 351.82%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.